Posey Phillip A. 4

4 · COMMUNITY HEALTH SYSTEMS INC · Filed Mar 3, 2026

AI-generated summary of this filing

Updated Mar 3, 2026

Community Health (CYH) SVP Phillip Posey Receives Awards

What Happened

Phillip A. Posey, Senior Vice President & Chief Accounting Officer of Community Health Systems (CYH), was granted three awards of 25,000 shares each on 2026-03-01 (total 75,000 restricted shares) and had 1,188 shares disposed/withheld to cover tax liability at $3.46 per share (total ~$4,110). The grants are reported at $0 acquisition price (compensation awards). The 1,188-share disposition is a tax withholding (routine), not an open‑market sale.

Key Details

Transaction date(s): 2026-03-01 (reported on Form 4 filed 2026-03-03).
Grants: three awards of 25,000 shares @ $0.00 (total 75,000 restricted shares). Two of the grants are indicated as derivative (performance-based).
Tax withholding/disposition: 1,188 shares @ $3.46 = $4,110 (code F — payment of tax liability).
Shares owned after transaction: not specified in the filing.
Filing timeliness: Form 4 was filed on 2026-03-03 for transactions dated 2026-03-01; the filing is not flagged as late.
Footnotes of note:
- F1/F3: Time‑vesting portions vest 1/3 on each of the first, second and third anniversaries of grant.
- F2: Performance‑based restricted shares vest based on results over the 2026–2028 performance period: 50% tied to cumulative same‑store adjusted EBITDA growth and 50% to cumulative same‑store net revenue growth. Vesting for each metric ranges from 0%–200% of target (the target number is reported).

Context

These transactions are grants of restricted stock (compensation/retention), not open‑market purchases or option exercises. The 1,188‑share disposition is a common tax withholding to satisfy tax obligations on the awards and is routine; it does not necessarily indicate insider bullish/bearish sentiment. Performance awards will only vest (and possibly adjust above/below target) based on the company’s results through 2028.

Form 4

Period: 2026-03-01

SVP & CAO

Transactions

Award
Common Stock
[F1]
2026-03-01+25,000→ 52,924 total
Tax Payment
Common Stock
2026-03-01$3.46/sh−1,188$4,110→ 51,736 total
Award
Performance Based Restricted
[F2]
2026-03-01+25,000→ 25,000 total
Exercise: $0.00→ Common Stock (25,000 underlying)
Award
Stock Options (Right to Buy)
[F3]
2026-03-01+25,000→ 25,000 total
Exercise: $3.46From: 2027-03-01Exp: 2036-02-29→ Common Stock (25,000 underlying)

Footnotes (3)

[F1]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
[F2]The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.
[F3]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Signature

Christopher G. Cobb, Attorney in Fact for Phillip A. Posey|2026-03-03

1 file